Holoclara Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$16M
- Investors
-
11
Holoclara General Information
Description
Provider of immunotherapy services intended to bring relief to people suffering from autoimmune disorders. The company offers a range of services, including the delivery of nematode-derived molecules with potent therapeutic properties and the identification of molecules derived from worm species to develop into safe, orally available therapeutics, enabling patients to lead a healthy and safe life.
Contact Information
Website
www.holoclara.comCorporate Office
- Post Office Box 515381
- PMB 24549
- Los Angeles, CA 90051
- United States
Corporate Office
- Post Office Box 515381
- PMB 24549
- Los Angeles, CA 90051
- United States
Holoclara Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 27-Jun-2024 | $16M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Sep-2019 | $5.7M | $5.7M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Holoclara Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed 3 | ||||||||
| Seed 2 | 691,637 | $0.000010 | $0.83 | $0.83 | 1x | $0.83 | 2.26% | |
| Seed 1 | 2,211,194 | $0.000010 | $0.78 | $0.78 | 1x | $0.78 | 7.21% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Holoclara Comparisons
Industry
Financing
Details
Holoclara Competitors (23)
One of Holoclara’s 23 competitors is Dendreon, a Formerly VC-backed company based in Seal Beach, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dendreon | Formerly VC-backed | Seal Beach, CA | ||||
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Allorion Therapeutics | Venture Capital-Backed | Natick, MA | ||||
| Navrogen | Venture Capital-Backed | Cheyney, PA |
Holoclara Patents
Holoclara Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220409650-A1 | Compositions and methods for ascaroside modification of mammalian microbiota | Inactive | 03-Jun-2019 | ||
| WO-2020247480-A1 | Compositions and methods for ascaroside modification of mammalian microbiota | Inactive | 03-Jun-2019 | ||
| CA-3140784-A1 | Ascaroside derivatives and methods of use | Pending | 17-May-2019 | ||
| EP-3969460-A1 | Ascaroside derivatives and methods of use | Pending | 17-May-2019 | ||
| EP-3969460-A4 | Ascaroside derivatives and methods of use | Pending | 17-May-2019 | A61K31/7028 |
Holoclara Signals
Holoclara Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endurance28 | Venture Capital | Minority | ||
| Freeflow Ventures | Venture Capital | Minority | ||
| Horizons Ventures | Venture Capital | Minority | ||
| K5 Global | Venture Capital | Minority | ||
| NIH Seed | Not-For-Profit Venture Capital | Minority |
Holoclara FAQs
-
When was Holoclara founded?
Holoclara was founded in 2017.
-
Where is Holoclara headquartered?
Holoclara is headquartered in Los Angeles, CA.
-
What is the size of Holoclara?
Holoclara has 7 total employees.
-
What industry is Holoclara in?
Holoclara’s primary industry is Drug Delivery.
-
Is Holoclara a private or public company?
Holoclara is a Private company.
-
What is the current valuation of Holoclara?
The current valuation of Holoclara is .
-
What is Holoclara’s current revenue?
The current revenue for Holoclara is .
-
How much funding has Holoclara raised over time?
Holoclara has raised $21.7M.
-
Who are Holoclara’s investors?
Endurance28, Freeflow Ventures, Horizons Ventures, K5 Global, and NIH Seed are 5 of 11 investors who have invested in Holoclara.
-
Who are Holoclara’s competitors?
Dendreon, Volastra, Ability Pharma, Allorion Therapeutics, and Navrogen are some of the 23 competitors of Holoclara.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process